MEI Pharma, Inc. (MEIP)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Jun 13, 2025

$2.29

P/E Ratio

N/A

Market Cap

$15.26M

Description
Add to research
View more

MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA.

Metrics
Add to research
View more

Overview

  • HQSan Diego, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerMEIP
  • Price$2.29+1.33%

Trading Information

  • Market cap$15.26M
  • Float98.69%
  • Average Daily Volume (1m)6,407
  • Average Daily Volume (3m)8,140
  • EPS-$4.75

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$2.57M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$2.77M
  • EV-$5.88M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.78
  • Debt/EquityN/A
Documents
Add to research
View more